133 related articles for article (PubMed ID: 34577783)
41. Multidimensional Screening Platform for Simultaneously Targeting Oncogenic KRAS and Hypoxia-Inducible Factors Pathways in Colorectal Cancer.
Bousquet MS; Ma JJ; Ratnayake R; Havre PA; Yao J; Dang NH; Paul VJ; Carney TJ; Dang LH; Luesch H
ACS Chem Biol; 2016 May; 11(5):1322-31. PubMed ID: 26938486
[TBL] [Abstract][Full Text] [Related]
42. Amplification of chromosome 8q21-qter associated with the acquired paclitaxel resistance of nasopharyngeal carcinoma cells.
Li W; You Y; Zhang X; Song Y; Xiang H; Peng X; Qin J; Tan G
Int J Clin Exp Pathol; 2015; 8(10):12346-56. PubMed ID: 26722421
[TBL] [Abstract][Full Text] [Related]
43. Chromosome 20q Amplification Defines a Subtype of Microsatellite Stable, Left-Sided Colon Cancers with Wild-type RAS/RAF and Better Overall Survival.
Ptashkin RN; Pagan C; Yaeger R; Middha S; Shia J; O'Rourke KP; Berger MF; Wang L; Cimera R; Wang J; Klimstra DS; Saltz L; Ladanyi M; Zehir A; Hechtman JF
Mol Cancer Res; 2017 Jun; 15(6):708-713. PubMed ID: 28184012
[TBL] [Abstract][Full Text] [Related]
44. 20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells.
Savelieva E; Belair CD; Newton MA; DeVries S; Gray JW; Waldman F; Reznikoff CA
Oncogene; 1997 Feb; 14(5):551-60. PubMed ID: 9053853
[TBL] [Abstract][Full Text] [Related]
45. Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer.
Tanner MM; Tirkkonen M; Kallioniemi A; Isola J; Kuukasjärvi T; Collins C; Kowbel D; Guan XY; Trent J; Gray JW; Meltzer P; Kallioniemi OP
Cancer Res; 1996 Aug; 56(15):3441-5. PubMed ID: 8758909
[TBL] [Abstract][Full Text] [Related]
46. Loss of heterozygosity of chromosome 20 in sporadic colorectal cancer.
Peng Z; Zhou C; Zhang F; Ling Y; Tang H; Bai S; Liu W; Qiu G; He L
Chin Med J (Engl); 2002 Oct; 115(10):1529-32. PubMed ID: 12490103
[TBL] [Abstract][Full Text] [Related]
47. Molecular subtypes of colorectal cancer in pre-clinical models show differential response to targeted therapies: Treatment implications beyond KRAS mutations.
Pal R; Wei N; Song N; Wu S; Kim RS; Wang Y; Gavin PG; Lucas PC; Srinivasan A; Allegra CJ; Jacobs SA; Paik S; Schmitz JC; Pogue-Geile KL
PLoS One; 2018; 13(8):e0200836. PubMed ID: 30118499
[TBL] [Abstract][Full Text] [Related]
48. Resistance to Selumetinib (AZD6244) in colorectal cancer cell lines is mediated by p70S6K and RPS6 activation.
Grasso S; Tristante E; Saceda M; Carbonell P; Mayor-López L; Carballo-Santana M; Carrasco-García E; Rocamora-Reverte L; García-Morales P; Carballo F; Ferragut JA; Martínez-Lacaci I
Neoplasia; 2014 Oct; 16(10):845-60. PubMed ID: 25379021
[TBL] [Abstract][Full Text] [Related]
49. EGFR Gene Amplification and KRAS Mutation Predict Response to Combination Targeted Therapy in Metastatic Colorectal Cancer.
Khan SA; Zeng Z; Shia J; Paty PB
Pathol Oncol Res; 2017 Jul; 23(3):673-677. PubMed ID: 28025786
[TBL] [Abstract][Full Text] [Related]
50. A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification.
Tarpgaard LS; Qvortrup C; Nygård SB; Nielsen SL; Andersen DR; Jensen NF; Stenvang J; Detlefsen S; Brünner N; Pfeiffer P
BMC Cancer; 2016 Feb; 16():91. PubMed ID: 26867764
[TBL] [Abstract][Full Text] [Related]
51. Biology of colorectal and gastric cancer cell lines.
Park JG; Gazdar AF
J Cell Biochem Suppl; 1996; 24():131-41. PubMed ID: 8806095
[TBL] [Abstract][Full Text] [Related]
52. Amplification of the E2F1 transcription factor gene in the HEL erythroleukemia cell line.
Saito M; Helin K; Valentine MB; Griffith BB; Willman CL; Harlow E; Look AT
Genomics; 1995 Jan; 25(1):130-8. PubMed ID: 7774910
[TBL] [Abstract][Full Text] [Related]
53. A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin.
Arena S; Corti G; Durinikova E; Montone M; Reilly NM; Russo M; Lorenzato A; Arcella P; Lazzari L; Rospo G; Pagani M; Cancelliere C; Negrino C; Isella C; Bartolini A; Cassingena A; Amatu A; Mauri G; Sartore-Bianchi A; Mittica G; Medico E; Marsoni S; Linnebacher M; Abrignani S; Siena S; Di Nicolantonio F; Bardelli A
Clin Cancer Res; 2020 Mar; 26(6):1372-1384. PubMed ID: 31831554
[TBL] [Abstract][Full Text] [Related]
54. Significant association of oncogene YAP1 with poor prognosis and cetuximab resistance in colorectal cancer patients.
Lee KW; Lee SS; Kim SB; Sohn BH; Lee HS; Jang HJ; Park YY; Kopetz S; Kim SS; Oh SC; Lee JS
Clin Cancer Res; 2015 Jan; 21(2):357-64. PubMed ID: 25388162
[TBL] [Abstract][Full Text] [Related]
55. High-resolution genomic profiles of human lung cancer.
Tonon G; Wong KK; Maulik G; Brennan C; Feng B; Zhang Y; Khatry DB; Protopopov A; You MJ; Aguirre AJ; Martin ES; Yang Z; Ji H; Chin L; Depinho RA
Proc Natl Acad Sci U S A; 2005 Jul; 102(27):9625-30. PubMed ID: 15983384
[TBL] [Abstract][Full Text] [Related]
56. Amplification of 8p11.23 in cancers and the role of amplicon genes.
Voutsadakis IA
Life Sci; 2021 Jan; 264():118729. PubMed ID: 33166592
[TBL] [Abstract][Full Text] [Related]
57. Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer.
Goyette MC; Cho K; Fasching CL; Levy DB; Kinzler KW; Paraskeva C; Vogelstein B; Stanbridge EJ
Mol Cell Biol; 1992 Mar; 12(3):1387-95. PubMed ID: 1347643
[TBL] [Abstract][Full Text] [Related]
58. Overexpression of the amplified Pip4k2beta gene from 17q11-12 in breast cancer cells confers proliferation advantage.
Luoh SW; Venkatesan N; Tripathi R
Oncogene; 2004 Feb; 23(7):1354-63. PubMed ID: 14691457
[TBL] [Abstract][Full Text] [Related]
59. Establishment and characterization of cell lines from chromosomal instable colorectal cancer.
Maletzki C; Gock M; Randow M; Klar E; Huehns M; Prall F; Linnebacher M
World J Gastroenterol; 2015 Jan; 21(1):164-76. PubMed ID: 25574089
[TBL] [Abstract][Full Text] [Related]
60. Engineering targeted chromosomal amplifications in human breast epithelial cells.
Springer S; Yi KH; Park J; Rajpurohit A; Price AJ; Lauring J
Breast Cancer Res Treat; 2015 Jul; 152(2):313-21. PubMed ID: 26099605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]